Key result
Angiotensin II type 2-receptor agonist C21 (1 mg/kg/day) protected against 4% high-sodium diet-induced kidney damage in obese Zucker rats by reducing oxidative stress and proteinuria.
Why the study?
Does angiotensin II type 2-receptor agonist C21 reduce renal damage and oxidative stress in high-salt-fed obese Zucker rats?
Does angiotensin II type 2-receptor agonist C21 reduce renal damage and oxidative stress in high-salt-fed obese Zucker rats?
Angiotensin II type 2-receptor activation with C21 protects against high-salt diet-induced kidney damage and oxidative stress in an obesity model.
AT2 agonism may attenuate HSD renal injury in obese rats; leaves open translation to human hypertensive nephropathy.
Oxidative and nitrosative stress have been implicated in high-sodium diet (HSD)-related hypertensive renal injury. In this study, we investigated angiotensin II type 2-receptor-mediated renoprotection in obese Zucker rats fed HSD. Obese Zucker rats were fed normal sodium diet or HSD 4%, for 14 days, with/without angiotensin II type 2-receptor agonist C21, delivered subcutaneously via osmotic pump, 1 mg/kg per day. Compared with normal sodium diet controls, HSD rats exhibited increase in cortical nicotinamide adenine dinucleotide phosphate oxidase activity, urinary H2O2, and 8-isoprostanes, which were associated with severe glomerulosclerosis, interstitial fibrosis, decline in estimated glomerular filtration rate, and an increase in urinary leak and activity of N-acetyl-β-D-glucosaminidase, a lysosomal enzyme and a marker of tubular damage. These changes were improved by C21 treatment. Cortical expression of endothelial nitric oxide synthase, phospho-endothelial nitric oxide synthase (Ser(1177)), and plasma nitrites were reduced after HSD intake, whereas nitrosative stress (3-nitrotyrosine) and enzymatic defense (superoxide dismutase-to-catalase activity) remained unaltered. However, C21 preserved plasma nitrites in HSD-fed obese Zucker rat. C21 treatment reduced protein-to-creatinine, albumin-to-creatinine, as well as fractional excretion of protein and albumin in HSD-fed obese Zucker rat, which is independent of changes in protein recycling receptors, megalin, and cubilin. HSD intake also altered renal excretory and reabsorptive capacity as evident by elevated plasma urea nitrogen-to-creatinine and fractional excretion of urea nitrogen, and reduced urine-to-plasma creatinine, which were modestly, but insignificantly, improved by C21 treatment. Together results demonstrate that angiotensin II type 2-receptor activation protects against HSD-induced kidney damage in obesity plausibly by reducing nicotinamide adenine dinucleotide phosphate oxidase activity and rescuing nitrites.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2016) studied High-sodium diet-related hypertensive renal injury in obesity. Angiotensin II type 2-receptor agonist C21 vs. High-sodium diet without C21 and normal sodium diet controls was evaluated on Proteinuria, oxidative stress, and kidney damage markers. Angiotensin II type 2-receptor agonist C21 (1 mg/kg/day) protected against 4% high-sodium diet-induced kidney damage in obese Zucker rats by reducing oxidative stress and proteinuria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: